First patient dosed in Phase 1b portion of ongoing Phase 1 study evaluating PHST001 in combination with chemotherapy Company to present three abstracts at AACR 2026, including preliminary clinical ...
Discover everything about 25 Captivating Interesting Facts That Will Blow Your Mind. Comprehensive guide with facts, insights ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
In new research, scientists at the Department of Energy's SLAC National Accelerator Laboratory, in collaboration with ...
If we figure out how to harness this effectively and efficiently, this is it. This is the end. This is the solution,” an ...
Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
The responding phage enters lysogeny prematurely, sparing the bacterial host and reducing competition for the signaling phage’s own progeny.
Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...